FDA Inspection 1041903 — Evonik Corporation
The FDA completed an inspection of Evonik Corporation on January 12, 2018 in Lafayette, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 12, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Lafayette, IN (United States)